CONTINUE TO SITE

OR WAIT null SECS

Advertisement

Carl Zeiss Case Studies High-Frequency Deep Sclerotomy A MIGS Procedure for Mild-to-Moderate Glaucoma iCare COMPASS Automated Perimeter

Carl Zeiss Case Studies High-Frequency Deep Sclerotomy A MIGS Procedure for Mild-to-Moderate Glaucoma iCare COMPASS Automated Perimeter

View More Cataract & Refractive Cornea Gene Therapy Glaucoma Inflammation & Infection Paediatrics Retina

Cataract & Refractive Cornea Gene Therapy Glaucoma Inflammation & Infection Paediatrics Retina

Medical World News

Eyeviews Medical World News Podcasts Rapid Readouts Viewpoints

Digital Edition

Supplements And Featured Publications

Digital Edition Supplements And Featured Publications

Conference Coverage

Conference Listing

Sponsored Resources

Zeiss Case Studies

Sponsored Resources Zeiss Case Studies

Print Subscription

eNewsletter Print Subscription

Advertise
Editorial Info
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2022 MJH Life Sciences and Opthalmology Times Europe. All rights reserved.

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Advertisement

Spotlight

Carl Zeiss Case Studies
High-Frequency Deep Sclerotomy A MIGS Procedure for Mild-to-Moderate Glaucoma
iCare COMPASS Automated Perimeter

ClinicalSee All >

Cataract & Refractive
Cornea
Gene Therapy
Glaucoma
Inflammation & Infection
Paediatrics
Retina

Advertise
Editorial Info
Contact Us
Terms and Conditions
Privacy
Do Not Sell My Personal Information

© 2022 MJH Life Sciences^™ and Opthalmology Times Europe. All rights reserved.

Seeing clearly

Published on: September 9, 2011

Balancing risk in ophthalmic prescribing for wet AMD

Related Content:

Sponsored Resources

Efficacy and safety of intravitreal aflibercept (Eylea®) therapy using a proactive treat-and-extend regimen in neovascular AMD

Keeping a step ahead of the disease: proactive treatment for nAMD

CenterVue EIDON FA: the FIRST Fully Automated Fluorescein Angiography system

Advertisement

Advertisement